Esperion Therapeutics Stock Chart

Add to My Stocks
$49.31 $0.06 (0.12%) ESPR stock closing price Sep 22, 2017 (Closing)

Esperion Therapeutics Net Income Chart

  • Download
    • Download PNG image
    • Download JPEG image
    • Download SVG image
    • Download PDF document
Embed
Compare with
AEGR net income
GEMP net income
REGN net income
TXMD net income
Esperion Therapeutics Net Income: Esperion Therapeutics Inc saw an an increase of net income by 6.91% from 2017-Q1 to 2017-Q2. The net income or bottom line is a line item in the income statement of a company's financials. The net profit is obtained by removing the COGS, expenses, and taxes from the firm's total income. The net income is always calculated for a given accounting period.